[1] Bush NA, Chang SM, Berger MS. Current and future strategies for treatment of glioma[J].Neurosurg Rev,2017, 40(1):1-14. [2] 张亚飞, 刘洪梅, 于如同. 负载siRNA药物治疗神经胶质瘤载体的研究进展[J].中华神经外科杂志, 2016, 32(3):322-324. [3] Baniyash M, Sade-Feldman M, Kanterman J. Chronic inflammation and cancer: suppressing the suppressors[J].Cancer Immunol Immunother,2014, 63(1):11-20. [4] Hu H, Yao X, Xie X,et al. Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients[J].World J Urol,2016, 35(2):1-10. [5] 陈新, 泮长存, 王宇, 等. 脑干神经节细胞胶质瘤的临床特征及外科治疗[J].中华神经外科杂志, 2017, 33(5):436-441. [6] Nicolásávila J, Adrover JM, Hidalgo A. Neutrophils in homeostasis, immunity, and cancer[J].Immunity,2017, 46(1):15-28. [7] Kros JM, Mustafa DM, Dekker LJM,et al. Circulating glioma biomarkers[J].Neuro Oncol,2015, 17(3):343-360. [8] Liu JS, Huang Y, Yang X,et al. A nomogram to predict prognostic values of various inflammatory biomarkers in patients with esophageal squamous cell carcinoma[J].Am J Cancer Res,2015, 5(7):2180-2189. [9] 王陈汉, 孙文博, 刘宇驰,等. 人脑胶质瘤细胞的原代培养及基本生长特性[J].临床神经外科杂志, 2017, 14(2):95-97. [10] Pandya H, Shen MJ, Ichikawa DM,et al.Differentiation of human and murine induced pluripotent stem cells to microglia-like cells[J].Nature Neurosci,2017, 20(5):753-759. [11] Rizzo D, Ruggiero A, Martini M,et al.Molecular biology in pediatric high-grade glioma: impact on prognosis and treatment[J].Biomed Res Int,2015, 2015(19):215135. [12] Hambardzumyan D, Gutmann DH, Kettenmann H. The role of microglia and macrophages in glioma maintenance and progression[J].Nature Neurosci,2015, 19(1):20-27. [13] Hamard L, Ratel D, Selek L,et al.The brain tissue response to surgical injury and its possible contribution to glioma recurrence[J].J Neuro Oncol,2016, 128(1):1-8.
2019, Vol. 36 
